<SEC-DOCUMENT>0001558370-20-001074.txt : 20200220
<SEC-HEADER>0001558370-20-001074.hdr.sgml : 20200220
<ACCEPTANCE-DATETIME>20200220160133
ACCESSION NUMBER:		0001558370-20-001074
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20191230
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200220
DATE AS OF CHANGE:		20200220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeuroBo Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37809
		FILM NUMBER:		20634987

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		734-245-1700

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY ST.
		STREET 2:		FL 19
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>f8-ka.htm
<DESCRIPTION>8-K/A
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.5.2.4-->
<!--Created on: 2/20/2020 2:01:22 PM-->
<html>
	<head>
		<title>
			nrbo_Current_Folio_8K-A
		</title>
	</head>
	<body><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p style="margin:0pt 0pt 2pt;border-bottom:1pt solid #000000 ;line-height:normal;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">WASHINGTON, D.C. 20549</font>
		</p>
		<p style="margin:0pt 0pt 2pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">FORM 8-K/A</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;color:#000000;">(Amendment No.&nbsp;3)</font>
		</p>
		<p style="margin:0pt 0pt 6pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">CURRENT REPORT</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">of the Securities Exchange Act of 1934</font>
		</p>
		<p style="margin:6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">Date of Report (Date of earliest event reported): December 30, 2019</font>
		</p>
		<p style="margin:0pt 0pt 2pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">NeuroBo Pharmaceuticals, Inc.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">(Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt 0pt 2pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
			<font style="display:inline;font-size:8pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Delaware</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">001-37809</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">47-2389984</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">(State or other jurisdiction</font></p>
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">of incorporation)</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">(Commission</font></p>
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">File Number)</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">(IRS Employer</font></p>
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Identification No.)</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="middle" style="width:auto;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="middle" style="width:auto;height:12.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">200 Berkeley Street, 19</font><font style="display:inline;font-weight:bold;font-size:6pt;top:-4.4pt;position:relative;line-height:115%">th</font><font style="display:inline;font-weight:bold;"> Floor</font></p>
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Boston, Massachusetts</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">02116</font></p>
				</td>
			</tr>
			<tr>
				<td colspan="3" valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">(Address of principal executive offices)</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">(Zip Code)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:6pt 0pt 0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">Registrant&#x2019;s telephone number, including area code: (857) 702-9600</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">Not applicable</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt 0pt 2pt;border-bottom:1pt solid #000000 ;line-height:normal;text-align:center;font-family:Times New Roman,Times,serif;font-size: 6pt;">
			<font style="display:inline;font-size:6pt;">&nbsp;</font>
		</p>
		<p style="margin:6pt 0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font>
		</p>
		<p style="margin:0pt 0pt 3pt 36pt;line-height:100%;text-indent: -36pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-family:MS Gothic;">&#x2610;<font style="display:inline;font-family:MS Gothic;;font-size: 11pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 29.7pt 0pt 0pt;"></font></font><font style="display:inline;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font>
		</p>
		<p style="margin:0pt 0pt 3pt 36pt;line-height:100%;text-indent: -36pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-family:MS Gothic;">&#x2610;<font style="display:inline;font-family:MS Gothic;;font-size: 11pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 29.7pt 0pt 0pt;"></font></font><font style="display:inline;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font>
		</p>
		<p style="margin:0pt 0pt 3pt 36pt;line-height:100%;text-indent: -36pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-family:MS Gothic;">&#x2610;<font style="display:inline;font-family:MS Gothic;;font-size: 11pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 29.7pt 0pt 0pt;"></font></font><font style="display:inline;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font>
		</p>
		<p style="margin:0pt 0pt 3pt 36pt;line-height:100%;text-indent: -36pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-family:MS Gothic;">&#x2610;<font style="display:inline;font-family:MS Gothic;;font-size: 11pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 29.7pt 0pt 0pt;"></font></font><font style="display:inline;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;line-height:100%;text-indent: -36pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">Securities registered pursuant to Section 12(b) of the Act:</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Title&nbsp;of&nbsp;each&nbsp;class</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Trading</font></p>
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Symbol(s)</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Name&nbsp;of&nbsp;each&nbsp;exchange</font></p>
					<p style="margin:0pt 0pt 1pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">on&nbsp;which&nbsp;registered</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">Common Stock, par value $0.001 per share</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">NRBO</font></p>
				</td>
				<td valign="bottom" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:auto;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;font-weight:bold;">The Nasdaq Stock Market, LLC</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:6pt 0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter).</font>
		</p>
		<p style="margin:0pt 0pt 6pt;line-height:100%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">Emerging growth company&nbsp;&nbsp;</font><font style="display:inline;font-family:MS Gothic;">&#x2612;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;</font><font style="display:inline;font-family:MS Gothic;">&#x2612;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-bottom:1pt solid #000000 ;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			&nbsp;
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-align:center;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;color:#000000;">EXPLANATORY NOTE</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-indent:36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">On December&nbsp;31, 2019, NeuroBo Pharmaceuticals,&nbsp;Inc., formerly known as Gemphire Therapeutics,&nbsp;Inc. (the &#x201C;Company&#x201D;), filed a Current Report on Form&nbsp;8&#8209;K, which was amended by Amendment No.&nbsp;1 to the Form&nbsp;8&#8209;K (filed on January&nbsp;7, 2020) and Amendment No.&nbsp;2 to the Form&nbsp;8&#8209;K (filed on January&nbsp;22, 2020) (as amended, the &#x201C;Form&nbsp;8&#8209;K&#x201D;). The Form 8-K reported the completion, on December&nbsp;30, 2019, of the Company&#x2019;s business combination with the private entity formerly known as NeuroBo Pharmaceuticals,&nbsp;Inc. (&#x201C;NeuroBo&#x201D;), in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of July&nbsp;24, 2019, as amended on October&nbsp;29, 2019, by and among the Company, NeuroBo and GR Merger Sub,&nbsp;Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#x201C;Merger Sub&#x201D;), pursuant to which, among other matters, Merger Sub merged with and into NeuroBo, with NeuroBo continuing as a wholly-owned subsidiary of the Company and the surviving corporation of the merger.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-indent:36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">This Amendment No.&nbsp;3 to the Form&nbsp;8&#8209;K is being filed&nbsp;to (i) include the consent of BDO USA, LLP with respect to the audited financial statements of NeuroBo as of and for the year ended December 31, 2018 and for the period from inception (July 25, 2017) to December 3l, 2017, which are incorporated by reference into the Form 8-K pursuant to Item 9.01(a) of Form 8-K, and (ii) to correct the addresses of the hyperlinks to Exhibits 2.1 and 2.2 to the Form 8-K, which linked to incorrect documents. The correct hyperlinks for Exhibits 2.1 and 2.2 are included herein under Item 9.01(d).</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-indent:36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">Except as stated in this Explanatory Note, there are no changes to the Form&nbsp;8&#8209;K.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;line-height:100%;text-indent: -36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;color:#000000;">Item&nbsp;9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;line-height:100%;text-indent: -36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-style:italic;color:#000000;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements of Business Acquired.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-indent:36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">Reference is made to the Proxy Statement, which included the audited financial statements of NeuroBo as of and for the&nbsp;year ended December&nbsp;31, 2018 and the period from inception (July 25, 2017) to December 31, 2017, which are incorporated herein by reference in satisfaction of the Item&nbsp;9.01(a)&nbsp;requirements for such information pursuant to General Instruction B.3 of Form&nbsp;8&#8209;K.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-indent:36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">The unaudited interim financial statements of NeuroBo, including NeuroBo&#x2019;s unaudited condensed consolidated balance sheet as of September&nbsp;30, 2019, NeuroBo&#x2019;s condensed consolidated balance sheet derived from audited financial statements as of December&nbsp;31, 2018, unaudited condensed consolidated statements of operations for the nine&nbsp;months ended September&nbsp;30, 2019 and 2018, unaudited condensed consolidated statements of cash flows for the nine&nbsp;months ended September&nbsp;30, 2019 and 2018 and the notes related thereto are filed as Exhibit&nbsp;99.2 to this report and incorporated herein by reference.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;line-height:100%;text-indent: -36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-style:italic;color:#000000;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro Forma Financial Information</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-indent:36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">The unaudited pro forma condensed combined financial information of the Company, including the unaudited pro forma condensed combined balance sheet as of September&nbsp;30, 2019, the unaudited pro forma condensed combined statement of operations for the nine&nbsp;months ended September&nbsp;30, 2019, the unaudited pro forma condensed combined statement of operations for the&nbsp;year ended December&nbsp;31, 2018 and the notes related thereto, is filed as Exhibit&nbsp;99.3 to this report and incorporated herein by reference.</font>
		</p>
		<p style="margin:0pt 0pt 8pt;color:#000000;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;font-style:italic;color:#000000;"></font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;line-height:100%;text-indent: -36pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-style:italic;color:#000000;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</font>
		</p>
		<p style="margin:0pt;line-height:100%;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:09.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:88.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:09.64%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:88.08%;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;overflow: hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:09.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Exhibit<br>No.</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:88.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:115%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">2.1&#xB1;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000155837019006287/ex-2d1.htm"><font style="display:inline;">Agreement and Plan of Merger and Reorganization, dated July&nbsp;24, 2019, by and among the Registrant, GR Merger Sub&nbsp;Inc. and NeuroBo Pharmaceuticals,&nbsp;Inc. (incorporated by reference from Exhibit&nbsp;2.1 to the Current Report on Form&nbsp;8&#8209;K filed with the SEC on July&nbsp;25, 2019, File No.&nbsp;001&#8209;37809).</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">2.2</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000155837019009361/ex-2d1.htm"><font style="display:inline;">First Amendment to Agreement and Plan of Merger and Reorganization, dated October&nbsp;29, 2019, by and among the Registrant, GR Merger Sub&nbsp;Inc. and NeuroBo Pharmaceuticals,&nbsp;Inc. (incorporated by reference from Exhibit&nbsp;2.1 to the Current Report on Form&nbsp;8&#8209;K, as filed with the Securities and Exchange Commission on October&nbsp;29, 2019, File No.&nbsp;001&#8209;37809).</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">3.1*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex3d1.htm"><font style="display:inline;">Certificate of Amendment (Reverse Stock Split) to the Third Amended and Restated Certificate of Incorporation of the Company.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">3.2*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex3d2.htm"><font style="display:inline;">Certificate of Amendment (Name Change) to the Third Amended and Restated Certificate of Incorporation of the Company.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">10.1+*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex10d1.htm"><font style="display:inline;">Contingent Value Rights Agreement, dated as of December&nbsp;30, 2019, by and among the Company, Grand Rapids Holders Representative, LLC, Computershare&nbsp;Inc. and Computershare Trust Company, N.A.</font></a> &nbsp;&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">10.2@*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex10d2.htm"><font style="display:inline;">2019 Equity Incentive Plan.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">10.3@*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex10d3.htm"><font style="display:inline;">Consulting Agreement by and between vZenium&nbsp;LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals,&nbsp;Inc., dated February&nbsp;1, 2018; Replacement Consulting Agreement, dated May&nbsp;1, 2018 and extension of such agreement, dated January&nbsp;1, 2019.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">10.4@*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex10d4.htm"><font style="display:inline;">Offer Letter, dated as of August&nbsp;20, 2018, by and between Nicola Shannon and NeuroBo.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">10.5@*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex10d5.htm"><font style="display:inline;">Form&nbsp;of Indemnification Agreement between NeuroBo Pharmaceuticals,&nbsp;Inc. and each of its directors and executive officers.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">16.1**</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465920001824/a20-1384_1ex16d1.htm"><font style="display:inline;">Letter from Ernst&nbsp;&amp; Young LLP</font></a>&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">23.1</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="ex-23d1.htm"><font style="display:inline;">Consent of BDO USA, LLP</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">99.1*</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000110465919076916/a19-28294_1ex99d1.htm"><font style="display:inline;">Press Release dated December&nbsp;30, 2019.</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">99.2***</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000155837020000207/nrbo-20191230ex9927f5c58.htm"><font style="display:inline;">Unaudited interim financial statements of NeuroBo</font></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:09.64%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<font style="display:inline;">99.3***</font></p>
				</td>
				<td valign="bottom" style="width:02.28%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-size:10pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:88.08%;padding:0pt;">
					<p style="margin:0pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
						<a href="http://www.sec.gov/Archives/edgar/data/1638287/000155837020000207/nrbo-20191230ex9937ad631.htm"><font style="display:inline;">Unaudited pro forma condensed combined financial statements</font></a></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:32.03%;height:.5pt;color:black;background-color:black;" align="left"></div>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt 18pt;line-height:100%;text-indent: -18pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">&#xB1;&nbsp;&nbsp;&nbsp;&nbsp;All schedules (or similar attachments) have been omitted from this filing pursuant to Item&nbsp;601(b)(2)&nbsp;of Regulation S-K. NeuroBo Pharmaceuticals,&nbsp;Inc. will furnish copies of any schedules to the U.S. Securities and Exchange Commission upon request.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 18pt;line-height:100%;text-indent: -18pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">@&nbsp;&nbsp;&nbsp;Management contract or compensatory plan or arrangement.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 18pt;line-height:100%;text-indent: -18pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Previously filed as exhibits to the Form&nbsp;8&#8209;K (filed on December&nbsp;31, 2019)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;text-indent: -18pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">**&nbsp;&nbsp;&nbsp;Previously filed as an exhibit to Amendment No.&nbsp;1 to the Form&nbsp;8&#8209;K (filed on January&nbsp;7, 2020)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;text-indent: -18pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:100%;text-indent: -18pt;color:#000000;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;color:#000000;">***&nbsp;&nbsp;Previously filed as an exhibit to Amendment No.&nbsp;2 to the Form&nbsp;8&#8209;K (filed on January&nbsp;22, 2020)</font>
		</p>
		<p style="margin:0pt 0pt 10pt;line-height:115%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;"></font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"><p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-weight:bold;">SIGNATURES</font>
		</p>
		<p style="margin:0pt 0pt 12pt;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:220.50pt;background-color: #auto;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:18.25pt;background-color: #auto;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:229.25pt;background-color: #auto;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:220.50pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 24pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:247.50pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt 0pt 24pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">NEUROBO PHARMACEUTICALS, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:220.50pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">Date: February 20, 2020</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:18.25pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:229.25pt;border-bottom:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;"> &nbsp;/s/ Richard Kang</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:220.50pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:18.25pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:229.25pt;border-top:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">Richard Kang</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:220.50pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:18.25pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:229.25pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;font-style:italic;">President and Chief Executive Officer</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:220.50pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:18.25pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:229.25pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex-23d1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!--HTML document created with Toppan Merrill Bridge  9.5.2.4-->
<!--Created on: 2/20/2020 2:01:21 PM-->
<html>
	<head>
		<title>
			nrbo_Ex_23.1
		</title>
	</head>
	<body><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;"></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p style="margin:0pt;background-color: #FFFFFF;text-align:right;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;color:#000000;font-size:10pt;">Exhibit 23.1</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;text-decoration:underline;">Consent of Independent Registered Public Accounting Firm</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">NeuroBo Pharmaceuticals,&nbsp;Inc.</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">Boston, Massachusetts</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">We hereby consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-232667, Form S-8 No. 333-225435, Form S-8 No. 333-222675, Form S-8 No. 333-213946, Form S-8 No. 333-213014, Form S-3 No. 333-220315 and Form S-3 No. 333-217296)&nbsp;&nbsp;of our report dated August 30, 2019, except for the subsequent events in Note&nbsp;10, as to which the dates are October&nbsp;10, 2019 and October&nbsp;29, 2019, relating to the consolidated financial statements of NeuroBo Pharmaceuticals,&nbsp;Inc. (the &#x201C;Company&#x201D;) appearing in the Company's Prospectus constituting a part of the Registration Statement on Form&nbsp;S-4 for the period from inception (July 25, 2017) to December 31, 2017 and the year ended December 31, 2018. Our report contains an explanatory paragraph regarding the Company&#x2019;s ability to continue as a going concern.</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">/s/ BDO USA, LLP</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">Boston, Massachusetts</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;border-top:1pt none #D9D9D9 ;color:#000000;line-height:100%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">February 20, 2020</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Calibri;line-height:107.92%;font-size: 11pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;">
		<p><font size="1"> </font></p></div><div style="margin-left:11.7647058823529%;margin-right:11.7647058823529%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
